These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 32013627)

  • 1. The dry powder inhaler features of the Easyhaler that benefit the management of patients.
    Chrystyn H; Lavorini F
    Expert Rev Respir Med; 2020 Apr; 14(4):345-351. PubMed ID: 32013627
    [No Abstract]   [Full Text] [Related]  

  • 2. Easyhaler
    Lavorini F
    Drugs Context; 2019; 8():212596. PubMed ID: 31210773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-life budesonide and formoterol dose emission from the medium and high strength fixed dosed combinations in a Spiromax® dry powder inhaler using inhalation profiles from patients with chronic obstructive pulmonary disease.
    Bagherisadeghi G; Chrystyn H; Abadelah M; Larhrib EH
    Eur J Pharm Sci; 2019 Nov; 139():105059. PubMed ID: 31472254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Budesonide + formoterol delivered via Spiromax
    Lewis A; Torvinen S; Dekhuijzen PNR; Chrystyn H; Melani A; Zöllner Y; Kolbe K; Watson AT; Blackney M; Plich A
    Respir Med; 2017 Aug; 129():179-188. PubMed ID: 28732829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of budesonide/formoterol pressurized metered-dose inhaler on exacerbations versus formoterol in chronic obstructive pulmonary disease: The 6-month, randomized RISE (Revealing the Impact of Symbicort in reducing Exacerbations in COPD) study.
    Ferguson GT; Tashkin DP; Skärby T; Jorup C; Sandin K; Greenwood M; Pemberton K; Trudo F
    Respir Med; 2017 Nov; 132():31-41. PubMed ID: 29229103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Difference in resistance to humidity between commonly used dry powder inhalers: an in vitro study.
    Janson C; Lööf T; Telg G; Stratelis G; Nilsson F
    NPJ Prim Care Respir Med; 2016 Nov; 26():16053. PubMed ID: 27853177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salbutamol Easyhaler provides non-inferior relief of methacholine induced bronchoconstriction in comparison to Ventoline Evohaler with spacer: A randomized trial.
    Karjalainen J; Vartiainen V; Tikkakoski A; Malmberg LP; Vuotari L; Lähelmä S; Sairanen U; Vahteristo M; Lehtimäki L
    Respir Med; 2024; 230():107693. PubMed ID: 38851404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The economic burden of asthma and chronic obstructive pulmonary disease and the impact of poor inhalation technique with commonly prescribed dry powder inhalers in three European countries.
    Lewis A; Torvinen S; Dekhuijzen PN; Chrystyn H; Watson AT; Blackney M; Plich A
    BMC Health Serv Res; 2016 Jul; 16():251. PubMed ID: 27406133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Equivalent Lung Dose and Systemic Exposure of Budesonide/Formoterol Combination via Easyhaler and Turbuhaler.
    Lähelmä S; Sairanen U; Haikarainen J; Korhonen J; Vahteristo M; Fuhr R; Kirjavainen M
    J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):462-73. PubMed ID: 25757188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of in vitro and in vivo flow rate dependency of budesonide/formoterol Easyhaler(®).
    Malmberg LP; Everard ML; Haikarainen J; Lähelmä S
    J Aerosol Med Pulm Drug Deliv; 2014 Oct; 27(5):329-40. PubMed ID: 24978441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Effectiveness of Budesonide/Formoterol Fumarate Easyhaler
    Tamási L; Szilasi M; Gálffy G
    Adv Ther; 2018 Aug; 35(8):1140-1152. PubMed ID: 30066185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Multicenter, Observational, Prospective Study of the Effectiveness of Switching from Budesonide/Formoterol Turbuhaler
    Syk J; Vinge I; Sörberg M; Vahteristo M; Rytilä P
    Adv Ther; 2019 Jul; 36(7):1756-1769. PubMed ID: 30941722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Onset of action of budesonide/formoterol Spiromax(®) compared with budesonide/formoterol Turbuhaler(®) in patients with COPD.
    Cazzola M; Ora J; Di Paolo A; Puxeddu E; Calzetta L; Rogliani P
    Pulm Pharmacol Ther; 2016 Aug; 39():48-53. PubMed ID: 27344046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of inhaler technique and achievement and maintenance of mastery of budesonide/formoterol Spiromax® compared with budesonide/formoterol Turbuhaler® in adult patients with asthma: the Easy Low Instruction Over Time (ELIOT) study.
    Price DB; Thomas V; Richard Dekhuijzen PN; Bosnic-Anticevich S; Roche N; Lavorini F; Raju P; Freeman D; Nicholls C; Small IR; Sims E; Safioti G; Canvin J; Chrystyn H
    BMC Pulm Med; 2018 Jun; 18(1):107. PubMed ID: 29954359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A narrative review on the Synchrobreathe™: A novel breath-actuated pressurised metered-dose inhaler for the treatment of obstructive airway diseases.
    Lavorini F; Usmani OS; Salvi S; Rote K; Gaur V; Gogtay J
    Respir Med; 2023; 219():107435. PubMed ID: 38652077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhaler competence and patient satisfaction with Easyhaler®: results of two real-life multicentre studies in asthma and COPD.
    Gálffy G; Mezei G; Németh G; Tamási L; Müller V; Selroos O; Orosz M
    Drugs R D; 2013 Sep; 13(3):215-22. PubMed ID: 24043456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The carbon footprint of as-needed budesonide/formoterol in mild asthma: a
    Hatter L; Holliday M; Eathorne A; Bruce P; Pavord ID; Reddel HK; Hancox RJ; Papi A; Weatherall M; Beasley R
    Eur Respir J; 2024 Jul; 64(1):. PubMed ID: 38609096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-world effectiveness evaluation of budesonide/formoterol Spiromax for the management of asthma and chronic obstructive pulmonary disease in the UK.
    Voorham J; Roche N; Benhaddi H; van der Tol M; Carter V; van Boven JFM; Bjermer L; Miravitlles M; Price DB
    BMJ Open; 2018 Oct; 8(10):e022051. PubMed ID: 30368448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Narrative Review of the Role of Patient-Reported Outcomes and Inhaler Handling Errors in the Control of Asthma and COPD.
    De Simón Gutiérrez R; Castro RP
    Curr Allergy Asthma Rep; 2022 Nov; 22(11):151-161. PubMed ID: 36087251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An innovative corticosteroid/long-acting β
    Usmani O; Roche N; Marshall J; Danagher H; Price D
    Expert Opin Drug Deliv; 2019 Dec; 16(12):1367-1380. PubMed ID: 31752560
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.